Dustin DeMoss, DO

  • 3Articles
  • 53.6KReads1
  • 2018–2022Active
  • 9Collaborators
  • 9Citations2

About

Dustin DeMoss, DO, is affiliated with John Peter Smith Health Network and the University of North Texas Health Science Center/Texas Christian University in Fort Worth, Texas. DeMoss has published on clinical topics including bipolar disorder, COVID-19-related neuropsychiatric conditions, neurology, Parkinson disease, and renal disease. Notable works include investigations into vaccine-induced psychosis, complications related to valproic acid therapy, and dopamine dysregulation syndrome prevention in Parkinson's disease. DeMoss has collaborated frequently with co-authors such as A. John Rush and Cheryl Hurd.

Publications

PCC
New-Onset Psychosis After COVID-19 Vaccine
Case Report

New-Onset Psychosis After COVID-19 Vaccine

November 15, 2022

A 45-year-old woman with no psychiatric history developed psychosis after receiving the COVID-19 vaccine. This report highlights that history of recent vaccine administration as a potential etiology deserves consideration...
, , , et al
PCC
Case Report

High Output Ileostomy Secondary to Subtherapeutic Valproic Acid

June 24, 2021

Diarrhea is a common side effect of divalproex sodium. Here, the authors present a geriatric case of divalproex sodium causing a high output despite numerous pharmacologic interventions.
, , , et al
PCC
Letter to the Editor

Dopamine Dysregulation Syndrome in Parkinson's Disease

April 26, 2018

Dopamine dysregulation syndrome (DDS) is a rare complication in patients with Parkinson's disease.  Patients with DDS typically take more than the recommended dose of dopamine replacement therapy and subsequently...
, ,

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe